» Articles » PMID: 35087404

Accentuating CircRNA-miRNA-Transcription Factors Axis: A Conundrum in Cancer Research

Overview
Journal Front Pharmacol
Date 2022 Jan 28
PMID 35087404
Authors
Affiliations
Soon will be listed here.
Abstract

Circular RNAs (circRNAs) are the newly uncovered class of non-coding RNAs being cognized as profound regulators of gene expression in developmental and disease biology. These are the covalently closed RNAs synthesized when the pre-mRNA transcripts undergo a back-splicing event. In recent years, circRNAs are gaining special attention in the scientific world and are no longer considered as "splicing noise" but rather structurally stable molecules having multiple biological functions including acting as miRNA sponges, protein decoys/scaffolds, and regulators of transcription and translation. Further, emerging evidence suggests that circRNAs are also differentially expressed in multiple cancers where they play oncogenic roles. In addition, circRNAs in association with miRNAs change the expression patterns of multiple transcription factors (TFs), which play important roles in cancer. Thus, the circRNA-miRNA-TFs axis is implicated in the progression or suppression of various cancer types and plays a role in cell proliferation, invasion, and metastasis. In this review article, we provide an outline of the biogenesis, localization, and functions of circRNAs specifically in cancer. Also, we highlight the regulatory function of the circRNA-miRNA-TFs axis in the progression or suppression of cancer and the targeting of this axis as a potential therapeutic approach for cancer management. We anticipate that our review will contribute to expanding the knowledge of the research community about this recent and rapidly growing field of circRNAs for further thorough investigation which will surely help in the management of deadly disease cancer.

Citing Articles

CircCENPM serves as a CeRNA to aggravate nasopharyngeal carcinoma metastasis and stemness via enhancing BMI1.

Wang R, Wang F Hereditas. 2025; 162(1):39.

PMID: 40087716 DOI: 10.1186/s41065-025-00406-7.


Exploring the role of noncoding RNAs in cancer diagnosis, prognosis, and precision medicine.

Eldakhakhny B, Sutaih A, Siddiqui M, Aqeeli Y, Awan A, Alsayegh M Noncoding RNA Res. 2025; 9(4):1315-1323.

PMID: 39764154 PMC: 11703603. DOI: 10.1016/j.ncrna.2024.06.015.


Unraveling the Regulatory Role of HuR/microRNA Axis in Colorectal Cancer Tumorigenesis.

Yadav V, Singh T, Sharma D, Garg V, Chakraborty P, Ghatak S Cancers (Basel). 2024; 16(18).

PMID: 39335155 PMC: 11430344. DOI: 10.3390/cancers16183183.


Roles and mechanisms of circular RNA in respiratory system cancers.

Yang N, Jiao M, Zhang Y, Mo S, Wang L, Liang J Front Oncol. 2024; 14:1430051.

PMID: 39077467 PMC: 11284073. DOI: 10.3389/fonc.2024.1430051.


Mucin 1 expression is regulated by hsa_circ_0055054/microRNA‑122‑5p and promotes hepatocellular carcinoma development.

Hao P, Li Q, Zhao H Oncol Lett. 2024; 28(3):404.

PMID: 38983125 PMC: 11228922. DOI: 10.3892/ol.2024.14537.


References
1.
Schmidt C, Giusto J, Bao A, Hopper A, Matera A . Molecular determinants of metazoan tricRNA biogenesis. Nucleic Acids Res. 2019; 47(12):6452-6465. PMC: 6614914. DOI: 10.1093/nar/gkz311. View

2.
Apte R, Chen D, Ferrara N . VEGF in Signaling and Disease: Beyond Discovery and Development. Cell. 2019; 176(6):1248-1264. PMC: 6410740. DOI: 10.1016/j.cell.2019.01.021. View

3.
Singh D, Khan M, Siddique H . Therapeutic implications of probiotics in microbiota dysbiosis: A special reference to the liver and oral cancers. Life Sci. 2021; 285:120008. DOI: 10.1016/j.lfs.2021.120008. View

4.
Ashwal-Fluss R, Meyer M, Pamudurti N, Ivanov A, Bartok O, Hanan M . circRNA biogenesis competes with pre-mRNA splicing. Mol Cell. 2014; 56(1):55-66. DOI: 10.1016/j.molcel.2014.08.019. View

5.
Li Z, Huang C, Bao C, Chen L, Lin M, Wang X . Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol. 2015; 22(3):256-64. DOI: 10.1038/nsmb.2959. View